Intech Investment Management LLC Trims Stock Holdings in Cabot Corporation $CBT

Intech Investment Management LLC reduced its holdings in shares of Cabot Corporation (NYSE:CBTFree Report) by 25.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,658 shares of the specialty chemicals company’s stock after selling 7,747 shares during the quarter. Intech Investment Management LLC’s holdings in Cabot were worth $1,699,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of CBT. Keeley Teton Advisors LLC lifted its position in shares of Cabot by 1.0% during the first quarter. Keeley Teton Advisors LLC now owns 16,756 shares of the specialty chemicals company’s stock worth $1,393,000 after acquiring an additional 174 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Cabot by 95.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock valued at $29,000 after purchasing an additional 189 shares during the period. Ferguson Wellman Capital Management Inc. lifted its holdings in Cabot by 4.2% during the 2nd quarter. Ferguson Wellman Capital Management Inc. now owns 5,000 shares of the specialty chemicals company’s stock worth $375,000 after purchasing an additional 200 shares in the last quarter. GAMMA Investing LLC boosted its stake in Cabot by 12.3% in the 2nd quarter. GAMMA Investing LLC now owns 1,909 shares of the specialty chemicals company’s stock worth $143,000 after purchasing an additional 209 shares during the period. Finally, CWM LLC grew its holdings in Cabot by 55.0% during the 1st quarter. CWM LLC now owns 600 shares of the specialty chemicals company’s stock valued at $50,000 after buying an additional 213 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Trading Up 5.2%

Shares of Cabot stock opened at $61.78 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 1.41. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $115.16. The firm has a market cap of $3.29 billion, a PE ratio of 8.08 and a beta of 0.90. The company has a 50 day simple moving average of $69.48 and a two-hundred day simple moving average of $74.33.

Cabot (NYSE:CBTGet Free Report) last issued its quarterly earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The company had revenue of $899.00 million during the quarter, compared to the consensus estimate of $967.02 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%.Cabot’s quarterly revenue was down 10.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.80 EPS. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Analysts expect that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 12th. Shareholders of record on Friday, November 28th will be given a dividend of $0.45 per share. The ex-dividend date is Friday, November 28th. This represents a $1.80 dividend on an annualized basis and a yield of 2.9%. Cabot’s dividend payout ratio (DPR) is presently 29.95%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CBT. Zacks Research downgraded shares of Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. UBS Group lowered their target price on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th. Finally, Mizuho decreased their price target on shares of Cabot from $78.00 to $72.00 and set an “outperform” rating on the stock in a report on Monday, November 17th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $74.00.

View Our Latest Report on Cabot

About Cabot

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Articles

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.